Infectious Disease Therapeutics Market Outlook:
Infectious Disease Therapeutics Market size was valued at USD 134.06 billion in 2025 and is set to exceed USD 196.54 billion by 2035, registering over 3.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of infectious disease therapeutics is estimated at USD 138.77 billion.
The infectious disease therapeutics market is witnessing significant growth lately, due to the rising prevalence of various infectious diseases, advancements in therapeutics treatments, and medical research. The consistent development in this field is driven by evolving trends such as gene editing technologies, immunotherapy combinations, nano-technology-based delivery systems, personalized consultations, and artificial intelligence-derived treatments. Genetically diverse populations across the globe are providing a significant opportunity for researchers, clinicians, and healthcare professionals to develop a precise healthcare framework with effective therapy interventions by leveraging genetic data and insights. Government agencies, pharmaceutical companies, and research institutions are striving together to explore advancement in the therapeutics field and address the global burden of infectious diseases.
